<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2005-08-02" modified="2018-01-31" version="161">
<accession>Q9BYF1</accession>
<accession>C7ECU1</accession>
<accession>Q6UWP0</accession>
<accession>Q86WT0</accession>
<accession>Q9NRA7</accession>
<accession>Q9UFZ6</accession>
<name>ACE2_HUMAN</name>
<protein>
<recommendedName>
<fullName>Angiotensin-converting enzyme 2</fullName>
<ecNumber>3.4.17.23</ecNumber>
</recommendedName>
<alternativeName>
<fullName>ACE-related carboxypeptidase</fullName>
</alternativeName>
<alternativeName>
<fullName>Angiotensin-converting enzyme homolog</fullName>
<shortName>ACEH</shortName>
</alternativeName>
<alternativeName>
<fullName>Metalloprotease MPROT15</fullName>
</alternativeName>
<component>
<recommendedName>
<fullName>Processed angiotensin-converting enzyme 2</fullName>
</recommendedName>
</component>
</protein>
<gene>
<name type="primary">ACE2</name>
<name type="ORF">UNQ868/PRO1885</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="2000" name="Circ. Res." volume="87" first="E1" last="E9">
<title>A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9.</title>
<authorList>
<person name="Donoghue M."/>
<person name="Hsieh F."/>
<person name="Baronas E."/>
<person name="Godbout K."/>
<person name="Gosselin M."/>
<person name="Stagliano N."/>
<person name="Donovan M."/>
<person name="Woolf B."/>
<person name="Robison K."/>
<person name="Jeyaseelan R."/>
<person name="Breitbart R.E."/>
<person name="Acton S."/>
</authorList>
<dbReference type="PubMed" id="10969042"/>
<dbReference type="DOI" id="10.1161/01.RES.87.5.e1"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>FUNCTION</scope>
<scope>ENZYME REGULATION</scope>
<source>
<tissue>Heart</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="2000" name="J. Biol. Chem." volume="275" first="33238" last="33243">
<title>A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase.</title>
<authorList>
<person name="Tipnis S.R."/>
<person name="Hooper N.M."/>
<person name="Hyde R."/>
<person name="Karran E."/>
<person name="Christie G."/>
<person name="Turner A.J."/>
</authorList>
<dbReference type="PubMed" id="10924499"/>
<dbReference type="DOI" id="10.1074/jbc.M002615200"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>GLYCOSYLATION</scope>
<scope>FUNCTION</scope>
<scope>ENZYME REGULATION</scope>
<source>
<tissue>Lymphoma</tissue>
</source>
</reference>
<reference key="3">
<citation type="journal article" date="2004" name="Endocrinology" volume="145" first="4703" last="4711">
<title>The novel angiotensin-converting enzyme (ACE) homolog, ACE2, is selectively expressed by adult Leydig cells of the testis.</title>
<authorList>
<person name="Douglas G.C."/>
<person name="O'Bryan M.K."/>
<person name="Hedger M.P."/>
<person name="Lee D.K.L."/>
<person name="Yarski M.A."/>
<person name="Smith A.I."/>
<person name="Lew R.A."/>
</authorList>
<dbReference type="PubMed" id="15231706"/>
<dbReference type="DOI" id="10.1210/en.2004-0443"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>ENZYME REGULATION</scope>
<source>
<tissue>Testis</tissue>
</source>
</reference>
<reference key="4">
<citation type="journal article" date="2005" name="Am. J. Med. Genet. A" volume="136" first="52" last="57">
<title>Identification of an alternative 5'-untranslated exon and new polymorphisms of angiotensin-converting enzyme 2 gene: lack of association with SARS in the Vietnamese population.</title>
<authorList>
<person name="Itoyama S."/>
<person name="Keicho N."/>
<person name="Hijikata M."/>
<person name="Quy T."/>
<person name="Phi N.C."/>
<person name="Long H.T."/>
<person name="Ha L.D."/>
<person name="Ban V.V."/>
<person name="Matsushita I."/>
<person name="Yanai H."/>
<person name="Kirikae F."/>
<person name="Kirikae T."/>
<person name="Kuratsuji T."/>
<person name="Sasazuki T."/>
</authorList>
<dbReference type="PubMed" id="15937940"/>
<dbReference type="DOI" id="10.1002/ajmg.a.30779"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>VARIANT SER-638</scope>
<source>
<tissue>Lung</tissue>
<tissue>Testis</tissue>
</source>
</reference>
<reference key="5">
<citation type="submission" date="2000-07" db="EMBL/GenBank/DDBJ databases">
<title>Cloning, expression analysis and chromosomal localization of a novel ACE like enzyme.</title>
<authorList>
<person name="Suzuki Y."/>
<person name="Watanabe M."/>
<person name="Sugano S."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
</reference>
<reference key="6">
<citation type="patent" date="1999-11-13" number="CA2248987">
<title>MPROT15 polypeptide and MPROT15 polynucleotide.</title>
<authorList>
<person name="Southan C."/>
<person name="Burgess N."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
</reference>
<reference key="7">
<citation type="submission" date="2009-06" db="EMBL/GenBank/DDBJ databases">
<title>Comparative susceptibility to SARS-CoV mediated by ACE2 protein of 15 different species.</title>
<authorList>
<person name="Li K.K.B."/>
<person name="Yip C.W."/>
<person name="Hon C.C."/>
<person name="Lam C.Y."/>
<person name="Leung F.C.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2003" name="Genome Res." volume="13" first="2265" last="2270">
<title>The secreted protein discovery initiative (SPDI), a large-scale effort to identify novel human secreted and transmembrane proteins: a bioinformatics assessment.</title>
<authorList>
<person name="Clark H.F."/>
<person name="Gurney A.L."/>
<person name="Abaya E."/>
<person name="Baker K."/>
<person name="Baldwin D.T."/>
<person name="Brush J."/>
<person name="Chen J."/>
<person name="Chow B."/>
<person name="Chui C."/>
<person name="Crowley C."/>
<person name="Currell B."/>
<person name="Deuel B."/>
<person name="Dowd P."/>
<person name="Eaton D."/>
<person name="Foster J.S."/>
<person name="Grimaldi C."/>
<person name="Gu Q."/>
<person name="Hass P.E."/>
<person name="Heldens S."/>
<person name="Huang A."/>
<person name="Kim H.S."/>
<person name="Klimowski L."/>
<person name="Jin Y."/>
<person name="Johnson S."/>
<person name="Lee J."/>
<person name="Lewis L."/>
<person name="Liao D."/>
<person name="Mark M.R."/>
<person name="Robbie E."/>
<person name="Sanchez C."/>
<person name="Schoenfeld J."/>
<person name="Seshagiri S."/>
<person name="Simmons L."/>
<person name="Singh J."/>
<person name="Smith V."/>
<person name="Stinson J."/>
<person name="Vagts A."/>
<person name="Vandlen R.L."/>
<person name="Watanabe C."/>
<person name="Wieand D."/>
<person name="Woods K."/>
<person name="Xie M.-H."/>
<person name="Yansura D.G."/>
<person name="Yi S."/>
<person name="Yu G."/>
<person name="Yuan J."/>
<person name="Zhang M."/>
<person name="Zhang Z."/>
<person name="Goddard A.D."/>
<person name="Wood W.I."/>
<person name="Godowski P.J."/>
<person name="Gray A.M."/>
</authorList>
<dbReference type="PubMed" id="12975309"/>
<dbReference type="DOI" id="10.1101/gr.1293003"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2)</scope>
</reference>
<reference key="9">
<citation type="submission" date="2003-01" db="EMBL/GenBank/DDBJ databases">
<authorList>
<consortium name="SeattleSNPs variation discovery resource"/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>VARIANT ARG-26</scope>
</reference>
<reference key="10">
<citation type="submission" date="2005-07" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
<source>
<tissue>Brain</tissue>
<tissue>Testis</tissue>
</source>
</reference>
<reference key="12">
<citation type="journal article" date="2007" name="BMC Genomics" volume="8" first="399" last="399">
<title>The full-ORF clone resource of the German cDNA consortium.</title>
<authorList>
<person name="Bechtel S."/>
<person name="Rosenfelder H."/>
<person name="Duda A."/>
<person name="Schmidt C.P."/>
<person name="Ernst U."/>
<person name="Wellenreuther R."/>
<person name="Mehrle A."/>
<person name="Schuster C."/>
<person name="Bahr A."/>
<person name="Bloecker H."/>
<person name="Heubner D."/>
<person name="Hoerlein A."/>
<person name="Michel G."/>
<person name="Wedler H."/>
<person name="Koehrer K."/>
<person name="Ottenwaelder B."/>
<person name="Poustka A."/>
<person name="Wiemann S."/>
<person name="Schupp I."/>
</authorList>
<dbReference type="PubMed" id="17974005"/>
<dbReference type="DOI" id="10.1186/1471-2164-8-399"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 2-805 (ISOFORM 1)</scope>
<source>
<tissue>Testis</tissue>
</source>
</reference>
<reference key="13">
<citation type="journal article" date="2004" name="Biochim. Biophys. Acta" volume="1689" first="175" last="178">
<title>Interaction of ACE2 and integrin beta1 in failing human heart.</title>
<authorList>
<person name="Lin Q."/>
<person name="Keller R.S."/>
<person name="Weaver B."/>
<person name="Zisman L.S."/>
</authorList>
<dbReference type="PubMed" id="15276642"/>
<dbReference type="DOI" id="10.1016/j.bbadis.2004.05.005"/>
</citation>
<scope>PROTEIN SEQUENCE OF 679-689</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
<scope>INTERACTION WITH ITGB1</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2002" name="FEBS Lett." volume="532" first="107" last="110">
<title>Quantitative mRNA expression profiling of ACE 2, a novel homologue of angiotensin converting enzyme.</title>
<authorList>
<person name="Harmer D."/>
<person name="Gilbert M."/>
<person name="Borman R."/>
<person name="Clark K.L."/>
</authorList>
<dbReference type="PubMed" id="12459472"/>
<dbReference type="DOI" id="10.1016/S0014-5793(02)03640-2"/>
</citation>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2002" name="J. Biol. Chem." volume="277" first="14838" last="14843">
<title>Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase.</title>
<authorList>
<person name="Vickers C."/>
<person name="Hales P."/>
<person name="Kaushik V."/>
<person name="Dick L."/>
<person name="Gavin J."/>
<person name="Tang J."/>
<person name="Godbout K."/>
<person name="Parsons T."/>
<person name="Baronas E."/>
<person name="Hsieh F."/>
<person name="Acton S."/>
<person name="Patane M.A."/>
<person name="Nichols A."/>
<person name="Tummino P."/>
</authorList>
<dbReference type="PubMed" id="11815627"/>
<dbReference type="DOI" id="10.1074/jbc.M200581200"/>
</citation>
<scope>BIOPHYSICOCHEMICAL PROPERTIES</scope>
<scope>ENZYME REGULATION</scope>
<scope>COFACTOR</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2003" name="Nature" volume="426" first="450" last="454">
<title>Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus.</title>
<authorList>
<person name="Li W."/>
<person name="Moore M.J."/>
<person name="Vasilieva N."/>
<person name="Sui J."/>
<person name="Wong S.-K."/>
<person name="Berne M.A."/>
<person name="Somasundaran M."/>
<person name="Sullivan J.L."/>
<person name="Luzuriaga K."/>
<person name="Greenough T.C."/>
<person name="Choe H."/>
<person name="Farzan M."/>
</authorList>
<dbReference type="PubMed" id="14647384"/>
<dbReference type="DOI" id="10.1038/nature02145"/>
</citation>
<scope>FUNCTION (MICROBIAL INFECTION)</scope>
<scope>INTERACTION WITH SARS-COV SPIKE GLYCOPROTEIN</scope>
<scope>GLYCOSYLATION</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2004" name="BMC Med." volume="2" first="19" last="19">
<title>ACE2 gene expression is up-regulated in the human failing heart.</title>
<authorList>
<person name="Goulter A.B."/>
<person name="Goddard M.J."/>
<person name="Allen J.C."/>
<person name="Clark K.L."/>
</authorList>
<dbReference type="PubMed" id="15151696"/>
<dbReference type="DOI" id="10.1186/1741-7015-2-19"/>
</citation>
<scope>INDUCTION</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2004" name="J. Pathol." volume="203" first="631" last="637">
<title>Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis.</title>
<authorList>
<person name="Hamming I."/>
<person name="Timens W."/>
<person name="Bulthuis M.L.C."/>
<person name="Lely A.T."/>
<person name="Navis G.J."/>
<person name="van Goor H."/>
</authorList>
<dbReference type="PubMed" id="15141377"/>
<dbReference type="DOI" id="10.1002/path.1570"/>
</citation>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2004" name="J. Virol." volume="78" first="11429" last="11433">
<title>Efficient replication of severe acute respiratory syndrome coronavirus in mouse cells is limited by murine angiotensin-converting enzyme 2.</title>
<authorList>
<person name="Li W."/>
<person name="Greenough T.C."/>
<person name="Moore M.J."/>
<person name="Vasilieva N."/>
<person name="Somasundaran M."/>
<person name="Sullivan J.L."/>
<person name="Farzan M."/>
<person name="Choe H."/>
</authorList>
<dbReference type="PubMed" id="15452268"/>
<dbReference type="DOI" id="10.1128/JVI.78.20.11429-11433.2004"/>
</citation>
<scope>FUNCTION (MICROBIAL INFECTION)</scope>
<scope>INTERACTION WITH SARS-COV SPIKE GLYCOPROTEIN</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2004" name="Mol. Cell. Proteomics" volume="3" first="715" last="728">
<title>A proteomic analysis of human bile.</title>
<authorList>
<person name="Kristiansen T.Z."/>
<person name="Bunkenborg J."/>
<person name="Gronborg M."/>
<person name="Molina H."/>
<person name="Thuluvath P.J."/>
<person name="Argani P."/>
<person name="Goggins M.G."/>
<person name="Maitra A."/>
<person name="Pandey A."/>
</authorList>
<dbReference type="PubMed" id="15084671"/>
<dbReference type="DOI" id="10.1074/mcp.M400015-MCP200"/>
</citation>
<scope>GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-90</scope>
<source>
<tissue>Bile</tissue>
</source>
</reference>
<reference key="21">
<citation type="journal article" date="2005" name="Eur. Heart J." volume="26" first="369" last="375">
<title>Myocardial infarction increases ACE2 expression in rat and humans.</title>
<authorList>
<person name="Burrell L.M."/>
<person name="Risvanis J."/>
<person name="Kubota E."/>
<person name="Dean R.G."/>
<person name="MacDonald P.S."/>
<person name="Lu S."/>
<person name="Tikellis C."/>
<person name="Grant S.L."/>
<person name="Lew R.A."/>
<person name="Smith A.I."/>
<person name="Cooper M.E."/>
<person name="Johnston C.I."/>
</authorList>
<dbReference type="PubMed" id="15671045"/>
<dbReference type="DOI" id="10.1093/eurheartj/ehi114"/>
</citation>
<scope>TISSUE SPECIFICITY</scope>
<scope>INDUCTION</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2005" name="EMBO J." volume="24" first="1634" last="1643">
<title>Receptor and viral determinants of SARS-coronavirus adaptation to human ACE2.</title>
<authorList>
<person name="Li W."/>
<person name="Zhang C."/>
<person name="Sui J."/>
<person name="Kuhn J.H."/>
<person name="Moore M.J."/>
<person name="Luo S."/>
<person name="Wong S.-K."/>
<person name="Huang I.-C."/>
<person name="Xu K."/>
<person name="Vasilieva N."/>
<person name="Murakami A."/>
<person name="He Y."/>
<person name="Marasco W.A."/>
<person name="Guan Y."/>
<person name="Choe H."/>
<person name="Farzan M."/>
</authorList>
<dbReference type="PubMed" id="15791205"/>
<dbReference type="DOI" id="10.1038/sj.emboj.7600640"/>
</citation>
<scope>FUNCTION (MICROBIAL INFECTION)</scope>
<scope>INTERACTION WITH SARS-COV SPIKE GLYCOPROTEIN</scope>
<scope>MUTAGENESIS</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2005" name="J. Biol. Chem." volume="280" first="30113" last="30119">
<title>Tumor necrosis factor-alpha convertase (ADAM17) mediates regulated ectodomain shedding of the severe-acute respiratory syndrome-coronavirus (SARS-CoV) receptor, angiotensin-converting enzyme-2 (ACE2).</title>
<authorList>
<person name="Lambert D.W."/>
<person name="Yarski M."/>
<person name="Warner F.J."/>
<person name="Thornhill P."/>
<person name="Parkin E.T."/>
<person name="Smith A.I."/>
<person name="Hooper N.M."/>
<person name="Turner A.J."/>
</authorList>
<dbReference type="PubMed" id="15983030"/>
<dbReference type="DOI" id="10.1074/jbc.M505111200"/>
</citation>
<scope>PROTEOLYTIC CLEAVAGE</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2005" name="Proc. Natl. Acad. Sci. U.S.A." volume="102" first="7988" last="7993">
<title>Human coronavirus NL63 employs the severe acute respiratory syndrome coronavirus receptor for cellular entry.</title>
<authorList>
<person name="Hofmann H."/>
<person name="Pyrc K."/>
<person name="van der Hoek L."/>
<person name="Geier M."/>
<person name="Berkhout B."/>
<person name="Poehlmann S."/>
</authorList>
<dbReference type="PubMed" id="15897467"/>
<dbReference type="DOI" id="10.1073/pnas.0409465102"/>
</citation>
<scope>FUNCTION (MICROBIAL INFECTION)</scope>
<scope>INTERACTION WITH HCOV-NL63 SPIKE GLYCOPROTEIN</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2009" name="J. Proteome Res." volume="8" first="651" last="661">
<title>Glycoproteomics analysis of human liver tissue by combination of multiple enzyme digestion and hydrazide chemistry.</title>
<authorList>
<person name="Chen R."/>
<person name="Jiang X."/>
<person name="Sun D."/>
<person name="Han G."/>
<person name="Wang F."/>
<person name="Ye M."/>
<person name="Wang L."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="19159218"/>
<dbReference type="DOI" id="10.1021/pr8008012"/>
</citation>
<scope>GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-546</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="26">
<citation type="journal article" date="2011" name="Biochemistry" volume="50" first="5182" last="5194">
<title>Angiotensin-converting enzyme 2 ectodomain shedding cleavage-site identification: determinants and constraints.</title>
<authorList>
<person name="Lai Z.W."/>
<person name="Hanchapola I."/>
<person name="Steer D.L."/>
<person name="Smith A.I."/>
</authorList>
<dbReference type="PubMed" id="21563828"/>
<dbReference type="DOI" id="10.1021/bi200525y"/>
</citation>
<scope>PROTEOLYTIC CLEAVAGE</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2011" name="J. Virol." volume="85" first="873" last="882">
<title>A transmembrane serine protease is linked to the severe acute respiratory syndrome coronavirus receptor and activates virus entry.</title>
<authorList>
<person name="Shulla A."/>
<person name="Heald-Sargent T."/>
<person name="Subramanya G."/>
<person name="Zhao J."/>
<person name="Perlman S."/>
<person name="Gallagher T."/>
</authorList>
<dbReference type="PubMed" id="21068237"/>
<dbReference type="DOI" id="10.1128/JVI.02062-10"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
<scope>PROTEOLYTIC CLEAVAGE</scope>
<scope>INTERACTION WITH TMPRSS2</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2014" name="J. Virol." volume="88" first="1293" last="1307">
<title>TMPRSS2 and ADAM17 cleave ACE2 differentially and only proteolysis by TMPRSS2 augments entry driven by the severe acute respiratory syndrome coronavirus spike protein.</title>
<authorList>
<person name="Heurich A."/>
<person name="Hofmann-Winkler H."/>
<person name="Gierer S."/>
<person name="Liepold T."/>
<person name="Jahn O."/>
<person name="Poehlmann S."/>
</authorList>
<dbReference type="PubMed" id="24227843"/>
<dbReference type="DOI" id="10.1128/JVI.02202-13"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>PROTEOLYTIC CLEAVAGE</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2004" name="J. Biol. Chem." volume="279" first="17996" last="18007">
<title>ACE2 X-ray structures reveal a large hinge-bending motion important for inhibitor binding and catalysis.</title>
<authorList>
<person name="Towler P."/>
<person name="Staker B."/>
<person name="Prasad S.G."/>
<person name="Menon S."/>
<person name="Tang J."/>
<person name="Parsons T."/>
<person name="Ryan D."/>
<person name="Fisher M."/>
<person name="Williams D."/>
<person name="Dales N.A."/>
<person name="Patane M.A."/>
<person name="Pantoliano M.W."/>
</authorList>
<dbReference type="PubMed" id="14754895"/>
<dbReference type="DOI" id="10.1074/jbc.M311191200"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS) OF 19-615</scope>
<scope>X-RAY CRYSTALLOGRAPHY (3.0 ANGSTROMS) OF 19-615 IN COMPLEX WITH MLN-4760</scope>
<scope>DISULFIDE BONDS</scope>
<scope>GLYCOSYLATION AT ASN-53; ASN-90; ASN-103; ASN-322; ASN-432 AND ASN-546</scope>
</reference>
<comment type="function">
<text evidence="7 8 11 27">Carboxypeptidase which converts angiotensin I to angiotensin 1-9, a peptide of unknown function, and angiotensin II to angiotensin 1-7, a vasodilator. Also able to hydrolyze apelin-13 and dynorphin-13 with high efficiency. May be an important regulator of heart function.</text>
</comment>
<comment type="function">
<text evidence="11 18 20 21">(Microbial infection) Acts as a receptor for SARS coronavirus/SARS-CoV and human coronavirus NL63/HCoV-NL63.</text>
</comment>
<comment type="catalytic activity">
<text>Angiotensin II + H(2)O = angiotensin-(1-7) + L-phenylalanine.</text>
</comment>
<comment type="cofactor">
<cofactor evidence="9">
<name>Zn(2+)</name>
<dbReference type="ChEBI" id="CHEBI:29105"/>
</cofactor>
<text evidence="9">Binds 1 zinc ion per subunit.</text>
</comment>
<comment type="cofactor">
<cofactor evidence="9">
<name>chloride</name>
<dbReference type="ChEBI" id="CHEBI:17996"/>
</cofactor>
<text evidence="9">Binds 1 Cl(-) ion per subunit.</text>
</comment>
<comment type="enzyme regulation">
<text evidence="7 8 9 16">Activated by chloride and fluoride, but not bromide. Inhibited by MLN-4760, cFP_Leu, and EDTA, but not by the ACE inhibitors linosipril, captopril and enalaprilat.</text>
</comment>
<comment type="biophysicochemical properties">
<kinetics>
<KM evidence="9">6.9 uM for angiotensin I</KM>
<KM evidence="9">2 uM for angiotensin II</KM>
<KM evidence="9">6.8 uM for apelin-13</KM>
<KM evidence="9">5.5 uM for dynorphin-13</KM>
</kinetics>
<phDependence>
<text evidence="9">Optimum pH is 6.5 in the presence of 1 M NaCl. Active from pH 6 to 9.</text>
</phDependence>
</comment>
<comment type="subunit">
<text evidence="12 17 25">Interacts with ITGB1. Interacts with the catalytically active form of TMPRSS2.</text>
</comment>
<comment type="subunit">
<text evidence="11 18 20 21">(Microbial infection) Interacts with SARS coronavirus/SARS-CoV and human coronavirus NL63/HCoV-NL63 spike glycoprotein (PubMed:14647384, PubMed:15452268, PubMed:15791205, PubMed:15897467).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-15814450"/>
<interactant intactId="EBI-15814420">
<id>Q6Q1S2</id>
<label>S</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="subcellular location">
<molecule>Processed angiotensin-converting enzyme 2</molecule>
<subcellularLocation>
<location>Secreted</location>
</subcellularLocation>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location>Cell membrane</location>
<topology>Single-pass type I membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location evidence="5">Cytoplasm</location>
</subcellularLocation>
<text evidence="5">Detected in both cell membrane and cytoplasm in neurons.</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>Q9BYF1-1</id>
<name>1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>Q9BYF1-2</id>
<name>2</name>
<sequence type="described" ref="VSP_014901 VSP_014902"/>
<text>No experimental confirmation available.</text>
</isoform>
</comment>
<comment type="tissue specificity">
<text evidence="7 8 10 14 16 19">Expressed in endothelial cells from small and large arteries, and in arterial smooth muscle cells. Expressed in lung alveolar epithelial cells, enterocytes of the small intestine, Leydig cells and Sertoli cells (at protein level). Expressed in heart, kidney, testis, and gastrointestinal system.</text>
</comment>
<comment type="induction">
<text evidence="15 19">Up-regulated in failing heart.</text>
</comment>
<comment type="PTM">
<text evidence="7 11 12 13 24">N-glycosylation on Asn-90 may limit SARS infectivity.</text>
</comment>
<comment type="PTM">
<text evidence="23 25 26 27">Proteolytic cleavage by ADAM17 generates a secreted form. Also cleaved by serine proteases: TMPRSS2, TMPRSS11D and HPN/TMPRSS1.</text>
</comment>
<comment type="similarity">
<text evidence="30">Belongs to the peptidase M2 family.</text>
</comment>
<comment type="online information" name="SeattleSNPs">
<link uri="http://pga.gs.washington.edu/data/ace2/"/>
</comment>
<dbReference type="EC" id="3.4.17.23"/>
<dbReference type="EMBL" id="AF291820">
<property type="protein sequence ID" value="AAF99721.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF241254">
<property type="protein sequence ID" value="AAF78220.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY623811">
<property type="protein sequence ID" value="AAT45083.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AB193259">
<property type="protein sequence ID" value="BAD99266.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AB193260">
<property type="protein sequence ID" value="BAD99267.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AB046569">
<property type="protein sequence ID" value="BAB40370.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="E39033">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="GQ262784">
<property type="protein sequence ID" value="ACT66268.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY358714">
<property type="protein sequence ID" value="AAQ89076.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY217547">
<property type="protein sequence ID" value="AAO25651.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471074">
<property type="protein sequence ID" value="EAW98892.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC039902">
<property type="protein sequence ID" value="AAH39902.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC048094">
<property type="protein sequence ID" value="AAH48094.2"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AL110224">
<property type="protein sequence ID" value="CAB53682.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS14169.1">
<molecule id="Q9BYF1-1"/>
</dbReference>
<dbReference type="PIR" id="T14762">
<property type="entry name" value="T14762"/>
</dbReference>
<dbReference type="RefSeq" id="NP_068576.1">
<molecule id="Q9BYF1-1"/>
<property type="nucleotide sequence ID" value="NM_021804.2"/>
</dbReference>
<dbReference type="UniGene" id="Hs.178098"/>
<dbReference type="PDB" id="1R42">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.20"/>
<property type="chains" value="A=1-615"/>
</dbReference>
<dbReference type="PDB" id="1R4L">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.00"/>
<property type="chains" value="A=1-615"/>
</dbReference>
<dbReference type="PDB" id="1XJP">
<property type="method" value="Model"/>
<property type="chains" value="B=19-615"/>
</dbReference>
<dbReference type="PDB" id="2AJF">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.90"/>
<property type="chains" value="A/B=19-615"/>
</dbReference>
<dbReference type="PDB" id="3D0G">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="A/B=56-615"/>
</dbReference>
<dbReference type="PDB" id="3D0H">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.10"/>
<property type="chains" value="A/B=56-615"/>
</dbReference>
<dbReference type="PDB" id="3D0I">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.90"/>
<property type="chains" value="A/B=56-615"/>
</dbReference>
<dbReference type="PDB" id="3KBH">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.31"/>
<property type="chains" value="A/B/C/D=19-615"/>
</dbReference>
<dbReference type="PDB" id="3SCI">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.90"/>
<property type="chains" value="A/B=19-615"/>
</dbReference>
<dbReference type="PDB" id="3SCJ">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.00"/>
<property type="chains" value="A/B=19-615"/>
</dbReference>
<dbReference type="PDB" id="3SCK">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.00"/>
<property type="chains" value="A/B=83-615"/>
</dbReference>
<dbReference type="PDB" id="3SCL">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.00"/>
<property type="chains" value="A/B=83-615"/>
</dbReference>
<dbReference type="PDBsum" id="1R42"/>
<dbReference type="PDBsum" id="1R4L"/>
<dbReference type="PDBsum" id="1XJP"/>
<dbReference type="PDBsum" id="2AJF"/>
<dbReference type="PDBsum" id="3D0G"/>
<dbReference type="PDBsum" id="3D0H"/>
<dbReference type="PDBsum" id="3D0I"/>
<dbReference type="PDBsum" id="3KBH"/>
<dbReference type="PDBsum" id="3SCI"/>
<dbReference type="PDBsum" id="3SCJ"/>
<dbReference type="PDBsum" id="3SCK"/>
<dbReference type="PDBsum" id="3SCL"/>
<dbReference type="ProteinModelPortal" id="Q9BYF1"/>
<dbReference type="SMR" id="Q9BYF1"/>
<dbReference type="BioGrid" id="121864">
<property type="interactions" value="6"/>
</dbReference>
<dbReference type="DIP" id="DIP-44689N"/>
<dbReference type="IntAct" id="Q9BYF1">
<property type="interactions" value="3"/>
</dbReference>
<dbReference type="MINT" id="MINT-4538816"/>
<dbReference type="STRING" id="9606.ENSP00000252519"/>
<dbReference type="BindingDB" id="Q9BYF1"/>
<dbReference type="ChEMBL" id="CHEMBL3736"/>
<dbReference type="DrugBank" id="DB00722">
<property type="generic name" value="Lisinopril"/>
</dbReference>
<dbReference type="DrugBank" id="DB00691">
<property type="generic name" value="Moexipril"/>
</dbReference>
<dbReference type="DrugBank" id="DB05203">
<property type="generic name" value="SPP1148"/>
</dbReference>
<dbReference type="DrugBank" id="DB05358">
<property type="generic name" value="TAK-491"/>
</dbReference>
<dbReference type="GuidetoPHARMACOLOGY" id="1614"/>
<dbReference type="MEROPS" id="M02.006"/>
<dbReference type="iPTMnet" id="Q9BYF1"/>
<dbReference type="PhosphoSitePlus" id="Q9BYF1"/>
<dbReference type="BioMuta" id="ACE2"/>
<dbReference type="DMDM" id="71658783"/>
<dbReference type="PaxDb" id="Q9BYF1"/>
<dbReference type="PeptideAtlas" id="Q9BYF1"/>
<dbReference type="PRIDE" id="Q9BYF1"/>
<dbReference type="Ensembl" id="ENST00000252519">
<molecule id="Q9BYF1-1"/>
<property type="protein sequence ID" value="ENSP00000252519"/>
<property type="gene ID" value="ENSG00000130234"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000427411">
<molecule id="Q9BYF1-1"/>
<property type="protein sequence ID" value="ENSP00000389326"/>
<property type="gene ID" value="ENSG00000130234"/>
</dbReference>
<dbReference type="GeneID" id="59272"/>
<dbReference type="KEGG" id="hsa:59272"/>
<dbReference type="UCSC" id="uc004cxa.2">
<molecule id="Q9BYF1-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="59272"/>
<dbReference type="DisGeNET" id="59272"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000130234.10"/>
<dbReference type="GeneCards" id="ACE2"/>
<dbReference type="HGNC" id="HGNC:13557">
<property type="gene designation" value="ACE2"/>
</dbReference>
<dbReference type="HPA" id="CAB026174"/>
<dbReference type="HPA" id="HPA000288"/>
<dbReference type="MIM" id="300335">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q9BYF1"/>
<dbReference type="OpenTargets" id="ENSG00000130234"/>
<dbReference type="PharmGKB" id="PA425"/>
<dbReference type="eggNOG" id="KOG3690">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="ENOG410XPJ3">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00520000055576"/>
<dbReference type="HOGENOM" id="HOG000292210"/>
<dbReference type="HOVERGEN" id="HBG000265"/>
<dbReference type="InParanoid" id="Q9BYF1"/>
<dbReference type="KO" id="K09708"/>
<dbReference type="OMA" id="DFLTAHH"/>
<dbReference type="OrthoDB" id="EOG091G033S"/>
<dbReference type="PhylomeDB" id="Q9BYF1"/>
<dbReference type="TreeFam" id="TF312861"/>
<dbReference type="BRENDA" id="3.4.15.1">
<property type="organism ID" value="2681"/>
</dbReference>
<dbReference type="BRENDA" id="3.4.17.23">
<property type="organism ID" value="2681"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2022377">
<property type="pathway name" value="Metabolism of Angiotensinogen to Angiotensins"/>
</dbReference>
<dbReference type="SABIO-RK" id="Q9BYF1"/>
<dbReference type="ChiTaRS" id="ACE2">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="Q9BYF1"/>
<dbReference type="GeneWiki" id="Angiotensin-converting_enzyme_2"/>
<dbReference type="GenomeRNAi" id="59272"/>
<dbReference type="PMAP-CutDB" id="Q9BYF1"/>
<dbReference type="PRO" id="PR:Q9BYF1"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome X"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000130234"/>
<dbReference type="CleanEx" id="HS_ACE2"/>
<dbReference type="Genevisible" id="Q9BYF1">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0009986">
<property type="term" value="C:cell surface"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0070062">
<property type="term" value="C:extracellular exosome"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005576">
<property type="term" value="C:extracellular region"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005615">
<property type="term" value="C:extracellular space"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0016021">
<property type="term" value="C:integral component of membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0045121">
<property type="term" value="C:membrane raft"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004180">
<property type="term" value="F:carboxypeptidase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004175">
<property type="term" value="F:endopeptidase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004181">
<property type="term" value="F:metallocarboxypeptidase activity"/>
<property type="evidence" value="ECO:0000269"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0001618">
<property type="term" value="F:virus receptor activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0008270">
<property type="term" value="F:zinc ion binding"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0002005">
<property type="term" value="P:angiotensin catabolic process in blood"/>
<property type="evidence" value="ECO:0000305"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0002003">
<property type="term" value="P:angiotensin maturation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0003051">
<property type="term" value="P:angiotensin-mediated drinking behavior"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0060452">
<property type="term" value="P:positive regulation of cardiac muscle contraction"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:1903598">
<property type="term" value="P:positive regulation of gap junction assembly"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:2000379">
<property type="term" value="P:positive regulation of reactive oxygen species metabolic process"/>
<property type="evidence" value="ECO:0000305"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0032800">
<property type="term" value="P:receptor biosynthetic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0046813">
<property type="term" value="P:receptor-mediated virion attachment to host cell"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0097746">
<property type="term" value="P:regulation of blood vessel diameter"/>
<property type="evidence" value="ECO:0000305"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1903779">
<property type="term" value="P:regulation of cardiac conduction"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0042127">
<property type="term" value="P:regulation of cell proliferation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0001817">
<property type="term" value="P:regulation of cytokine production"/>
<property type="evidence" value="ECO:0000305"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0050727">
<property type="term" value="P:regulation of inflammatory response"/>
<property type="evidence" value="ECO:0000305"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0003081">
<property type="term" value="P:regulation of systemic arterial blood pressure by renin-angiotensin"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0019229">
<property type="term" value="P:regulation of vasoconstriction"/>
<property type="evidence" value="ECO:0000305"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0015827">
<property type="term" value="P:tryptophan transport"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0046718">
<property type="term" value="P:viral entry into host cell"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="CDD" id="cd06461">
<property type="entry name" value="M2_ACE"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="1.20.5.100">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR031588">
<property type="entry name" value="Collectrin_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR021157">
<property type="entry name" value="Cyt_c1_TM_anchor_C"/>
</dbReference>
<dbReference type="InterPro" id="IPR001548">
<property type="entry name" value="Peptidase_M2"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR10514">
<property type="entry name" value="PTHR10514"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF16959">
<property type="entry name" value="Collectrin"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF01401">
<property type="entry name" value="Peptidase_M2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR00791">
<property type="entry name" value="PEPDIPTASEA"/>
</dbReference>
<dbReference type="PROSITE" id="PS00142">
<property type="entry name" value="ZINC_PROTEASE"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0121">Carboxypeptidase</keyword>
<keyword id="KW-1003">Cell membrane</keyword>
<keyword id="KW-0868">Chloride</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0903">Direct protein sequencing</keyword>
<keyword id="KW-1015">Disulfide bond</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-1183">Host cell receptor for virus entry</keyword>
<keyword id="KW-0945">Host-virus interaction</keyword>
<keyword id="KW-0378">Hydrolase</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0479">Metal-binding</keyword>
<keyword id="KW-0482">Metalloprotease</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-0645">Protease</keyword>
<keyword id="KW-0675">Receptor</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0964">Secreted</keyword>
<keyword id="KW-0732">Signal</keyword>
<keyword id="KW-0812">Transmembrane</keyword>
<keyword id="KW-1133">Transmembrane helix</keyword>
<keyword id="KW-0862">Zinc</keyword>
<feature type="signal peptide" evidence="6">
<location>
<begin position="1"/>
<end position="17"/>
</location>
</feature>
<feature type="chain" description="Angiotensin-converting enzyme 2" id="PRO_0000028570">
<location>
<begin position="18"/>
<end position="805"/>
</location>
</feature>
<feature type="chain" description="Processed angiotensin-converting enzyme 2" id="PRO_0000292268">
<location>
<begin position="18"/>
<end position="708"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="6">
<location>
<begin position="18"/>
<end position="740"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="6">
<location>
<begin position="741"/>
<end position="761"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="6">
<location>
<begin position="762"/>
<end position="805"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with SARS-CoV spike glycoprotein">
<location>
<begin position="30"/>
<end position="41"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with SARS-CoV spike glycoprotein">
<location>
<begin position="82"/>
<end position="84"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with SARS-CoV spike glycoprotein">
<location>
<begin position="353"/>
<end position="357"/>
</location>
</feature>
<feature type="region of interest" description="Essential for cleavage by ADAM17">
<location>
<begin position="652"/>
<end position="659"/>
</location>
</feature>
<feature type="region of interest" description="Essential for cleavage by TMPRSS11D and TMPRSS2">
<location>
<begin position="697"/>
<end position="716"/>
</location>
</feature>
<feature type="active site">
<location>
<position position="375"/>
</location>
</feature>
<feature type="active site">
<location>
<position position="505"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc; catalytic">
<location>
<position position="374"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc; catalytic">
<location>
<position position="378"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc; catalytic">
<location>
<position position="402"/>
</location>
</feature>
<feature type="binding site" description="Chloride">
<location>
<position position="169"/>
</location>
</feature>
<feature type="binding site" description="Substrate">
<location>
<position position="273"/>
</location>
</feature>
<feature type="binding site" description="Substrate">
<location>
<position position="345"/>
</location>
</feature>
<feature type="binding site" description="Substrate; via carbonyl oxygen">
<location>
<position position="346"/>
</location>
</feature>
<feature type="binding site" description="Substrate">
<location>
<position position="371"/>
</location>
</feature>
<feature type="binding site" description="Chloride">
<location>
<position position="477"/>
</location>
</feature>
<feature type="binding site" description="Chloride">
<location>
<position position="481"/>
</location>
</feature>
<feature type="binding site" description="Substrate">
<location>
<position position="515"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="31">
<location>
<position position="53"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="12 13">
<location>
<position position="90"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="12">
<location>
<position position="103"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="31">
<location>
<position position="322"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="12">
<location>
<position position="432"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="12 24">
<location>
<position position="546"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="6">
<location>
<position position="690"/>
</location>
</feature>
<feature type="disulfide bond" evidence="12">
<location>
<begin position="133"/>
<end position="141"/>
</location>
</feature>
<feature type="disulfide bond" evidence="12">
<location>
<begin position="344"/>
<end position="361"/>
</location>
</feature>
<feature type="disulfide bond" evidence="12">
<location>
<begin position="530"/>
<end position="542"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_014901" evidence="29">
<original>F</original>
<variation>L</variation>
<location>
<position position="555"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_014902" evidence="29">
<location>
<begin position="556"/>
<end position="805"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs4646116." id="VAR_023082" evidence="28">
<original>K</original>
<variation>R</variation>
<location>
<position position="26"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs183135788." id="VAR_023083" evidence="22">
<original>N</original>
<variation>S</variation>
<location>
<position position="638"/>
</location>
</feature>
<feature type="mutagenesis site" description="Slightly inhibits interaction with SARS-CoV spike glycoprotein." evidence="20">
<original>QAK</original>
<variation>KAE</variation>
<location>
<begin position="24"/>
<end position="26"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes interaction with SARS-CoV spike glycoprotein." evidence="20">
<original>K</original>
<variation>D</variation>
<location>
<position position="31"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on interaction with SARS-CoV spike glycoprotein." evidence="20">
<original>E</original>
<variation>A</variation>
<location>
<position position="37"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on interaction with SARS-CoV spike glycoprotein." evidence="20">
<original>D</original>
<variation>A</variation>
<location>
<position position="38"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strongly inhibits interaction with SARS-CoV spike glycoprotein." evidence="20">
<original>Y</original>
<variation>A</variation>
<location>
<position position="41"/>
</location>
</feature>
<feature type="mutagenesis site" description="Slightly inhibits interaction with SARS-CoV spike glycoprotein." evidence="20">
<original>K</original>
<variation>D</variation>
<location>
<position position="68"/>
</location>
</feature>
<feature type="mutagenesis site" description="Inhibits interaction with SARS-CoV spike glycoprotein." evidence="20">
<original>MYP</original>
<variation>NFS</variation>
<location>
<begin position="82"/>
<end position="84"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on interaction with SARS-CoV spike glycoprotein." evidence="20">
<original>E</original>
<variation>P</variation>
<location>
<position position="110"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on interaction with SARS-CoV spike glycoprotein." evidence="20">
<original>PD</original>
<variation>SM</variation>
<location>
<begin position="135"/>
<end position="136"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on interaction with SARS-CoV spike glycoprotein." evidence="20">
<original>E</original>
<variation>R</variation>
<location>
<position position="160"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on interaction with SARS-CoV spike glycoprotein." evidence="20">
<original>R</original>
<variation>D</variation>
<location>
<position position="192"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on interaction with SARS-CoV spike glycoprotein." evidence="20">
<original>R</original>
<variation>D</variation>
<location>
<position position="219"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on interaction with SARS-CoV spike glycoprotein." evidence="20">
<original>H</original>
<variation>Q</variation>
<location>
<position position="239"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on interaction with SARS-CoV spike glycoprotein." evidence="20">
<original>K</original>
<variation>D</variation>
<location>
<position position="309"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on interaction with SARS-CoV spike glycoprotein." evidence="20">
<original>E</original>
<variation>A</variation>
<location>
<position position="312"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on interaction with SARS-CoV spike glycoprotein." evidence="20">
<original>T</original>
<variation>A</variation>
<location>
<position position="324"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on interaction with SARS-CoV spike glycoprotein." evidence="20">
<original>NVQ</original>
<variation>DDR</variation>
<location>
<begin position="338"/>
<end position="340"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on interaction with SARS-CoV spike glycoprotein." evidence="20">
<original>D</original>
<variation>A</variation>
<location>
<position position="350"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes interaction with SARS-CoV spike glycoprotein." evidence="20">
<original>K</original>
<variation>H</variation>
<variation>A</variation>
<variation>D</variation>
<location>
<position position="353"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strongly inhibits interaction with SARS-CoV spike glycoprotein." evidence="20">
<original>D</original>
<variation>A</variation>
<location>
<position position="355"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strongly inhibits interaction with SARS-CoV spike glycoprotein." evidence="20">
<original>R</original>
<variation>A</variation>
<location>
<position position="357"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on interaction with SARS-CoV spike glycoprotein." evidence="20">
<original>L</original>
<variation>K</variation>
<variation>A</variation>
<location>
<position position="359"/>
</location>
</feature>
<feature type="mutagenesis site" description="Slightly inhibits interaction with SARS-CoV spike glycoprotein." evidence="20">
<original>M</original>
<variation>A</variation>
<location>
<position position="383"/>
</location>
</feature>
<feature type="mutagenesis site" description="Slightly inhibits interaction with SARS-CoV spike glycoprotein." evidence="20">
<original>P</original>
<variation>A</variation>
<location>
<position position="389"/>
</location>
</feature>
<feature type="mutagenesis site" description="Slightly inhibits interaction with SARS-CoV spike glycoprotein." evidence="20">
<original>R</original>
<variation>A</variation>
<location>
<position position="393"/>
</location>
</feature>
<feature type="mutagenesis site" description="Slightly inhibits interaction with SARS-CoV spike glycoprotein." evidence="20">
<original>SPD</original>
<variation>PSN</variation>
<location>
<begin position="425"/>
<end position="427"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on interaction with SARS-CoV spike glycoprotein." evidence="20">
<original>KGE</original>
<variation>QDK</variation>
<location>
<begin position="465"/>
<end position="467"/>
</location>
</feature>
<feature type="mutagenesis site" description="Slightly inhibits interaction with SARS-CoV spike glycoprotein." evidence="20">
<original>R</original>
<variation>S</variation>
<location>
<position position="559"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on interaction with SARS-CoV spike glycoprotein." evidence="20">
<original>F</original>
<variation>T</variation>
<location>
<position position="603"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 12; CAB53682." ref="12" evidence="30">
<original>Q</original>
<variation>H</variation>
<location>
<position position="18"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 8; AAQ89076." ref="8" evidence="30">
<original>N</original>
<variation>D</variation>
<location>
<position position="508"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 5; BAB40370." ref="5" evidence="30">
<original>K</original>
<variation>R</variation>
<location>
<position position="631"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="23"/>
<end position="52"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="56"/>
<end position="77"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="78"/>
<end position="82"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="85"/>
<end position="87"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="91"/>
<end position="100"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="104"/>
<end position="107"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="110"/>
<end position="129"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="131"/>
<end position="134"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="137"/>
<end position="143"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="144"/>
<end position="146"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="148"/>
<end position="154"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="158"/>
<end position="171"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="173"/>
<end position="193"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="196"/>
<end position="198"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="199"/>
<end position="204"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="205"/>
<end position="207"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="213"/>
<end position="215"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="220"/>
<end position="251"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="253"/>
<end position="255"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="258"/>
<end position="260"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="264"/>
<end position="266"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="267"/>
<end position="271"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="276"/>
<end position="278"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="279"/>
<end position="282"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="284"/>
<end position="287"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="294"/>
<end position="297"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="298"/>
<end position="300"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="304"/>
<end position="316"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="317"/>
<end position="319"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="327"/>
<end position="330"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="338"/>
<end position="340"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="347"/>
<end position="352"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="355"/>
<end position="359"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="366"/>
<end position="384"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="385"/>
<end position="387"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="390"/>
<end position="392"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="400"/>
<end position="413"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="415"/>
<end position="420"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="422"/>
<end position="426"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="432"/>
<end position="446"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="449"/>
<end position="465"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="466"/>
<end position="468"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="470"/>
<end position="472"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="473"/>
<end position="483"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="486"/>
<end position="488"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="499"/>
<end position="502"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="504"/>
<end position="507"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="514"/>
<end position="531"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="532"/>
<end position="534"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="539"/>
<end position="541"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="548"/>
<end position="558"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="559"/>
<end position="562"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="566"/>
<end position="574"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="575"/>
<end position="578"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="582"/>
<end position="598"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="600"/>
<end position="602"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="607"/>
<end position="609"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1R42"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1R4L"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3D0G"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3SCJ"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000250"/>
<evidence key="6" type="ECO:0000255"/>
<evidence key="7" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10924499"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10969042"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11815627"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12459472"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14647384"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14754895"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15084671"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15141377"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15151696"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15231706"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15276642"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15452268"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15671045"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15791205"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15897467"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15937940"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15983030"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19159218"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21068237"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21563828"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24227843"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source ref="9"/>
</evidence>
<evidence key="29" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="12975309"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000305"/>
<evidence key="31" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="14754895"/>
</source>
</evidence>
<sequence length="805" mass="92463" checksum="8EE6EB0A931550E8" modified="2005-08-02" version="2" precursor="true">
MSSSSWLLLSLVAVTAAQSTIEEQAKTFLDKFNHEAEDLFYQSSLASWNYNTNITEENVQ
NMNNAGDKWSAFLKEQSTLAQMYPLQEIQNLTVKLQLQALQQNGSSVLSEDKSKRLNTIL
NTMSTIYSTGKVCNPDNPQECLLLEPGLNEIMANSLDYNERLWAWESWRSEVGKQLRPLY
EEYVVLKNEMARANHYEDYGDYWRGDYEVNGVDGYDYSRGQLIEDVEHTFEEIKPLYEHL
HAYVRAKLMNAYPSYISPIGCLPAHLLGDMWGRFWTNLYSLTVPFGQKPNIDVTDAMVDQ
AWDAQRIFKEAEKFFVSVGLPNMTQGFWENSMLTDPGNVQKAVCHPTAWDLGKGDFRILM
CTKVTMDDFLTAHHEMGHIQYDMAYAAQPFLLRNGANEGFHEAVGEIMSLSAATPKHLKS
IGLLSPDFQEDNETEINFLLKQALTIVGTLPFTYMLEKWRWMVFKGEIPKDQWMKKWWEM
KREIVGVVEPVPHDETYCDPASLFHVSNDYSFIRYYTRTLYQFQFQEALCQAAKHEGPLH
KCDISNSTEAGQKLFNMLRLGKSEPWTLALENVVGAKNMNVRPLLNYFEPLFTWLKDQNK
NSFVGWSTDWSPYADQSIKVRISLKSALGDKAYEWNDNEMYLFRSSVAYAMRQYFLKVKN
QMILFGEEDVRVANLKPRISFNFFVTAPKNVSDIIPRTEVEKAIRMSRSRINDAFRLNDN
SLEFLGIQPTLGPPNQPPVSIWLIVFGVVMGVIVVGIVILIFTGIRDRKKKNKARSGENP
YASIDISKGENNPGFQNTDDVQTSF
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>